Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Oct;100(1):113-20.
doi: 10.1007/s11060-010-0146-4. Epub 2010 Feb 27.

Factors affecting prognosis of patients with intracranial anaplastic oligodendrogliomas: a single institutional review of 70 patients

Affiliations
Review

Factors affecting prognosis of patients with intracranial anaplastic oligodendrogliomas: a single institutional review of 70 patients

Liu-song Yang et al. J Neurooncol. 2010 Oct.

Abstract

Anaplastic oligodendroglioma (AO) is an uncommon intracranial tumor and prognosis is poor. In this study, we assessed the factors affecting the prognosis of AO patients. Seventy AO patients were recruited from 2001 to 2006 in Shanghai Huashan Hospital of Fudan University; all were treated surgically. Kaplan-Meier survival analysis and Cox regression analysis were used to analyze the prognostic effects of 14 different factors, which were selected from clinical, radiological, pathological, and treatment variables. The results showed that chemotherapy, age, primary or secondary tumors, preoperative Karnofsky Performance Scale (KPS) scores, the presence of epilepsy at initial presentation, radiological contrast infusion, and neurological parameters all correlated with the prognosis of the patients. Furthermore, Cox multivariate analysis also showed that the age (P < 0.048), primary or secondary tumors (P < 0.010), and chemotherapy (P < 0.010) were significantly correlated with the prognosis of the patients. Age and chemotherapy correlated with the prognosis of AO. The patients younger than 50 years old and who received regular chemotherapy were likely to achieve a good outcome. Moreover, individualized treatment after molecular biological typing of AO may improve the prognosis of AO.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Neurooncol. 2002 Sep;59(3):231-7 - PubMed
    1. J Neuropathol Exp Neurol. 2003 Nov;62(11):1118-28 - PubMed
    1. Am J Clin Oncol. 2000 Apr;23(2):170-5 - PubMed
    1. J Neuropathol Exp Neurol. 2007 Jun;66(6):545-51 - PubMed
    1. Neurosurgery. 1999 Dec;45(6):1279-91; discussion 191 - PubMed

MeSH terms

LinkOut - more resources